The hope is a partnership. Like what we thought was Novartis. But real!
It's a different disease and this time there is P3 data to look at whilst embarking on a new one and the FDA seems to be shining a torch on the path (somewhat).
MSB's 'hand' in negotiating the deal for this one is now heavily weighted towards their benefit.
The upside (maybe) is the world knows SI has a massive set of testicles so don't even bother if the money isn't right!! Or his unique conditions (whatever the hell they are - I have guessed previously).
Whispers in the wind will be at an all time high now I reckon. By the looks of the SP movements in advance of the announcements recently, the whispers started a few days ago.
Ann: FDAs OTAT Agrees to Primary Endpoint for Back Pain, page-129
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.52 |
Change
0.055(3.77%) |
Mkt cap ! $1.729B | |||
| Open | High | Low | Value | Volume |
| $1.48 | $1.54 | $1.45 | $6.072M | 4.049M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5951 | $1.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.52 | 133644 | 5 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |